Top Biotech Companies in Denver & Boulder, CO (61)
With 30+ years of experience, 28+ locations, and 2,000+ clinical studies conducted, Elite Clinical Network (ECN) is a trusted leader in clinical research. Our dedicated network of research sites is built on personalized service, investigator diversity, and rigorous quality processes to ensure excellence in every study. Backed by a professional corporate management team, we partner with top physicians across diverse specialties...
Our DATA for LIFE® mantra celebrates Pyxant Labs’ participation in an industry which saves lives. We fulfill an essential role in the drug development process. We have developed seminal capabilities directly supporting a cure for hepatitis, antiviral therapeutics for HIV, a fundamental understanding of Alzheimer’s Disease, antisense therapeutics, and now therapeutics for COVID-19. Founded in 2000, Pyxant Labs is a leading...
Waters Corporation (NYSE: WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 60 years. With more than 7,800 employees worldwide, Waters operates directly in 35 countries, including 14 manufacturing facilities, and with products available in more than 100 countries. Learn...
At Accure, we are wholly committed to developing revolutionary solutions to provide a long- lasting, durable treatment for acne. We know that acne can have a devastating social, psychological, physical, and economic impact on patients around the world. We are pioneering transformative solutions that will answer this unmet need and have a positive and profound impact on patients and providers worldwide.
10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock. We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of...
IDEXX's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results show double‑digit top‑line increases in 2025 and early 2026, with Q1 and Q2 2026 up 14% and 10% reported, respectively, and full‑year 2026 revenue guidance raised. Growth is broad‑based across Companion Animal Group diagnostics, Water, and LPD.
Profitability: Margin expansion is attributed to recurring diagnostics volume, pricing, and productivity, translating into higher EPS and operating leverage. Guidance and quarterly updates highlight continued earnings growth if these drivers are maintained.
Strong Market Position & Advantage: The company is widely regarded as the category leader in companion‑animal diagnostics, reinforced by an integrated ecosystem of instruments, consumables, labs, imaging, and software. Independent analyses consistently place it at or near the top across key diagnostics segments, supporting durable advantage.
Ensign-Bickford Industries, Inc. (EBI), founded in 1836, is a privately-owned high technology conglomerate focused in space & defense, pet food science, and biotechnology. We participate in businesses that are relevant to the future of the world and have multigenerational growth prospects. EBI companies are unified by a common shared operating system and a common set of values.
Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.
Asimov's Top Stability & Growth Strengths
Strategic Partnerships: Meaningful partnerships with blue‑chip players (e.g., Cytiva, LOTTE Biologics, Novo Nordisk, AGC Biologics) signal third‑party validation and channels for broader adoption of its platform.
Product Line Growth: Product launches and updates across CHO Edge, LV Edge, and AAV Edge (including stable AAV producer cell lines and CHO Edge Rapid Pools) indicate an expanding offering aimed at biologics and gene therapy workflows.
Investor Backing & Capital Strength: Raising over $200M provides financial runway to scale R&D and commercialization and supports continued platform build‑out through 2024–2026.
RTI International is an independent, nonprofit research institute dedicated to improving the human condition. Clients rely on us to answer questions that demand an objective and multidisciplinary approach—one that integrates expertise across the social and laboratory sciences, engineering, and international development. We believe in the promise of science, and we are inspired every day to deliver on that promise for...
Sartorius is a leading international partner of life sciences research and biopharmaceutical manufacturing. We help our customers #SimplifyProgress from drug discovery to manufacturing so that more people can have access to better medicine. With this, we are #PartOfTheSolution in the fight against diseases worldwide. With innovative laboratory instruments and consumables, the our Lab Products & Services division focuses on laboratories performing...
Sartorius's Top Stability & Growth Strengths
Strong Market Position & Advantage: Independent market analyses repeatedly characterize Sartorius as a top‑tier leader in single‑use bioprocessing, particularly in single‑use bioreactors, bags/assemblies, and integrated upstream platforms. Broad scale from bench to 2,000‑L, a large installed base, and continued capacity expansions reinforce this position.
Strong Revenue Growth: Company disclosures indicate sales grew 7.6% in constant currencies in 2025 to about €3.54 billion, with Q1 2026 up 7.5% and full‑year 2026 guidance of 5–9% growth. Order intake recovery from late 2024 and momentum in Bioprocess Solutions underpin this trend.
Profitability: Underlying EBITDA increased faster than sales in 2025, with margin near 30%, and management expects robust margins into 2026. Improving cash generation and recurring consumables contribute to sustained profitability.
What if you could repair broken genes? That is the question we ask ourselves every day at Editas Medicine. We’re a leading genome editing company focused on translating the power and promise of our proprietary genome editing systems into medicines to help transform the lives of people with genetically-defined diseases. Our goal is to discover, develop, manufacture, and commercialize transformative...
Horizon Ag-Products, LLC is a science and research-driven producer of innovative, naturally-derived plant health solutions for the global agricultural market. The company specializes in increasing nutrient uptake efficiency to improve fertilizer performance and maximize crop quality and yields. Its mission is to enable sustainable farming and environmental stewardship worldwide by providing scientifically-proven, naturally-derived products.
Front Range Biosciences is a value-driven agricultural biotech company with the mission to improve society by applying science to high-value crops. Our goal is to become a trusted global leader in agricultural technology, coffee, and hemp products using our innovative Clean Stock nurseries, quality breeding programs, and contemporary seed testing.
ADInstruments is committed to providing innovative tools for research and education. Our company helps scientists and educators achieve their goals with our industry leading PowerLab and LabChart data acquisition systems. Since 1988, life science research has been and continues to be a key driver for innovation in our research product line. Today there are 40,000 ADInstruments data acquisition systems used...
We believe in the power of technology to improve lives, from new opportunities and mission-critical functionality to user experience. Our team is proud to partner with passionate companies focused on reducing energy consumption, curing disease, improving education, building smart cities, and more – and with leading Cloud providers, including Amazon Web Services (AWS) and Microsoft Azure.
MBio Diagnostics is now LightDeck Diagnostics! LightDeck Diagnostics believes in a new approach to healthcare, where fast, accurate, simple, low-cost diagnostic tests will be run wherever and whenever they are needed, without compromise. The company’s proprietary LightDeck® platform combines an advanced laser waveguide with novel materials and patented manufacturing techniques to deliver lab-quality results anywhere, in minutes. LightDeck is introducing a...
Our Mission Our mission is to unite biopharma, physicians, and patients to transform the standard of care and improve outcomes with personalized diagnostics. Our Vision We envision a world where all critical diseases are diagnosed early and treated quickly with the guidance of personalized diagnostic solutions, so humanity can thrive without the burden of disease.
Materion (NYSE: MTRN) is one of the world’s premier advanced materials solutions providers. At Materion, we are committed to developing, manufacturing and marketing highly engineered advanced materials for global customers across a wide range of markets, including consumer electronics, defense and science, industrial and aerospace, automotive electronics, telecommunications infrastructure, appliances, medical and energy. Our products, processes and expertise help enable...
At Enveda, we are systematically translating molecules found in medicinal plants into new drugs for challenging diseases. Our platform harnesses nature's complexity with the help of cutting-edge advancements in knowledge graphs, machine learning, and metabolomics.
Aytu BioPharma (NASDAQ: AYTU) is a dynamic specialty pharmaceutical company with a growing commercial portfolio of prescription medicines addressing complex conditions, with a focus on ADHD and other common conditions. Our evolution has been driven by strategic in-licensing, acquisition-based transactions and organic product growth. As we continue on this trajectory, we continue to evaluate novel therapeutics to in-license or acquire....
Enrich is the leader in biotech and pharmaceutical portfolio management software, used in over half of the top 10 life sciences companies to value and manage portfolios of high risk, high investment assets. Our proprietary suite of tailored analytics and flexible on-demand visualizations are ideally suited for portfolio management.



































